Skip to content
CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Media Room

Explore our latest press releases, announcements, and updates on groundbreaking immunotherapy research.

For media inquiries, please contact us at [email protected].

  • Media Room Article

    Cancer Research Institute Announces Fall 2024 CRI Irvington and Immuno-Informatics Fellows Advancing Cancer Immunotherapy 

    NEW YORK, NY – The Cancer Research Institute (CRI) is proud to announce its Fall 2024 class…
    February 11, 2025
  • Media Room Article

    Cancer Research Institute Appoints New Chief Development and Operations Officers to Drive Growth and Innovation

    NEW YORK, NY — The Cancer Research Institute (CRI) is pleased to announce the addition of two…
    October 22, 2024
  • Media Room Article

    Immunotherapy Titans to Be Honored for Scientific Excellence at CRI’s 2024 Annual Awards Gala

    NEW YORK—October 8, 2024—The Cancer Research Institute (CRI) will celebrate groundbreaking achievements in immunotherapy at its 2024…
    October 8, 2024
  • Media Room Article

    The Cancer Research Institute and the Kidney Cancer Association Announce a Collaboration to Co-Fund Kidney Cancer Immunotherapy Research  

    NEW YORK, NY and HOUSTON, TX — The Cancer Research Institute (CRI) is proud to announce a…
    September 24, 2024
  • Alicia Zhou

    Media Room Article

    Cancer Research Institute (CRI) Appoints Alicia Zhou, PhD, as Chief Executive Officer to Advance Next Generation of Cancer Immunotherapy Science and Innovation

    NEW YORK, NY — The Cancer Research Institute (CRI), the preeminent nonprofit organization focused on advancing breakthroughs…
    September 9, 2024
  • Media Room Article

    Global Experts Converge at CICON24 to Unveil Groundbreaking Advances in Cancer Immunotherapy, September 8-11, 2024 at National Harbor, MD

    NATIONAL HARBOR, MD – The Cancer Research Institute (CRI) and the European Network for Cancer Immunotherapy (ENCI)…
    September 6, 2024
  • Media Room Article

    The 2024 Impact Report of the Cancer Research Institute

    Executive Summary   Since our founding in 1953, the Cancer Research Institute (CRI) has been at the forefront…
    August 9, 2024
  • Media Room Article

    Cancer Research Institute Awards Over $22 Million in Grants to Fuel Immunotherapy Innovations

    NEW YORK – August 8, 2024 — As the leading nonprofit organization committed to revolutionizing cancer treatment…
    August 8, 2024
  • Media Room Article

    Cancer Research Institute Announces New Lloyd J. Old STARs Class

    New York, NY – August 5, 2024 – The Cancer Research Institute (CRI) proudly announces the newest…
    August 5, 2024
Previous Page
1 2 3 4 5 … 23
Next Page
Father and son

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

See ways to give

Uniting for a World
Immune to Cancer

Stay Up To Date

Get Patient Stories & Research Updates


Donate By Mail

Cancer Research Institute
29 Broadway, Floor 4
New York, NY 10006-3111

Quick Links

  • Our Annual Impact
  • Blog
  • Careers
  • Contact Us
  • Donate

Trusted & Top-Rated charity

Charity Navigator
Candid Platinum Transparency 2026
Charity Watch Top Rated
BBB Accredited Business

connect with Us

LinkedIn icon
Facebook Icon
X icon
Instagram icon
YouTube icon

The Cancer Research Institute is a 501(c)(3) charitable organization. Our Federal Tax ID Number is 13-1837442.

©2026 Cancer Research Institute

*Immunotherapy results may vary from patient to patient.

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
Trigger Donate Modal